https://orcid.org/0000-0002-8012-1974
References
- Choi YM, Adelzadeh L, Wu JJ. Non-tuberculous mycobacterial infections in psoriasis patients treated with biologics. J Eur Acad Dermatol Venereol. 2016;30(10):e99–e101.
- Lim A, Allison C, Price P, et al. Susceptibility to pulmonary disease due to Mycobacterium avium-intracellulare complex may reflect low IL-17 and high IL-10 responses rather than Th1 deficiency. Clin Immunol. 2010;137(2):296–302.
- Heidarnezhad F, Asnaashari A, Rezaee SA, et al. Evaluation of Interleukin17and Interleukin 23 expression in patients with active and latent tuberculosis infection. Iran J Basic Med Sci. 2016;19(8):844–850.
- Becker KL, van Ingen J, Ten Oever J, et al. Deficient interleukin-17 production in response to Mycobacterium abscessus in cystic fibrosis. Eur Respir J. 2016;47(3):990–993.
- Furukawa BS, Flume PA. Nontuberculous Mycobacteria in Cystic Fibrosis. Semin Respir Crit Care Med. 2018;39(3):383–391.
- Vazquez N, Rekka S, Gliozzi M, et al. Modulation of innate host factors by Mycobacterium avium complex in human macrophages includes interleukin 17. J Infect Dis. 2012;206(8):1206–1217.
- Brode SK, Jamieson FB, Ng R, et al. Increased risk of mycobacterial infections associated with anti-rheumatic medications. Thorax. 2015;70(7):677–682.
- Shu CC, Wang JY, Wu MF, et al. Interleukin 23/interleukin 17 axis activated by Mycobacterium avium complex (MAC) is attenuated in patients with MAC-lung disease. Tuberculosis (Edinb). 2018;110:7–14.
- Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol. 2009;27(1):393–422.
- Stark MA, Huo Y, Burcin TL, et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity. 2005;22(3):285–294.